ArticleCancer medicine2020

Dynamic changes of bone metastasis predict bone-predominant status to benefit from radium-223 dichloride for patients with castration-resistant prostate cancer.

Kohei Hashimoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.